TipRanks
Go Ultimate55% OFF

Benson Hill (BHILQ) AI Stock Analysis

Top Page

BHILQ

Benson Hill

(Other OTC:BHILQ)

Select Model
Rating:39Underperform
Action:N/A
Date:02/01/25

Benson Hill's stock score reflects significant financial challenges, including declining revenues and high leverage, which are the primary concerns. The technical analysis does not show signs of recovery, and the negative valuation metrics further contribute to the low score. Improvements in cash flow management are noted but are insufficient to offset the broader financial instability.

Positive Factors
Innovative Business ModelBenson Hill's innovative approach using its CropOS platform positions it to capitalize on trends in sustainable agriculture, offering a competitive edge in developing nutritious and sustainable food solutions.
Negative Factors
High LeverageHigh leverage can strain financial flexibility and increase risk, potentially limiting the company's ability to invest in growth opportunities and weather economic downturns.

Benson Hill (BHILQ) vs. SPDR S&P 500 ETF (SPY)

-100%-80%-60%-40%-20%0%20%BHILQ-82.14%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$611
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
0.0
Beta (1Y)
-24829.19
Revenue Growth
―
EPS Growth
―
Country
US
Employees
270
Sector
Basic Materials
Sector Strength
61
Industry
Agricultural Inputs

Benson Hill Business Overview & Revenue Model

Company Description

Benson Hill, Inc., including its subsidiaries, operates as an innovative food technology company focused on leveraging the natural genetic variation within plants. The organization's activities are divided into two main areas: Ingredients and Fresh....

How the Company Makes Money

Benson Hill generates revenue primarily through its proprietary CropOS platform and its associated plant breeding and biotechnology services. The company earns money by developing and licensing improved crop varieties, which are designed to enhance y...

Benson Hill Earnings Call Summary

Earnings Call Date:Mar 13, 2024(Q4-2023)|% Change Since:-99.86%|Next Earnings Date:Mar 11, 2025
Earnings Call SentimentNeutral

The earnings call presented significant achievements such as revenue growth, debt reduction, and cost-cutting success, positioning the company for future opportunities. However, challenges remain with goodwill impairment, expected revenue decline in 2024 due to asset divestitures, and concerns over cash burn. The company is in a transition phase, focusing on leveraging its technology and strategic partnerships.

Positive Updates

Revenue Growth
Benson Hill reported consolidated revenues of $473 million, a 24% year-over-year improvement, driven by a 52% revenue growth in proprietary and 18% growth in nonproprietary grain products.

Negative Updates

Goodwill Impairment and Nonrecurring Costs
Total operating expenses included $19 million in goodwill impairment and $13 million in net charges related to nonrecurring severance and other costs.

Company Guidance

During the Benson Hill Q4 2023 earnings call, management provided a comprehensive update on the company's strategic initiatives and financial performance metrics. The company reported consolidated revenues of $473 million for 2023, marking a 24% year-over-year improvement, with proprietary grain products growing by 52% and nonproprietary grain products by 18%. Gross profit reached $23 million, more than tripling the prior year's figure, while adjusted EBITDA showed a loss of $48 million, improved by over 40% from the previous year. The company successfully reduced recurring operating expenses (OpEx) and capital expenditures (CapEx) by more than 33% and ended the year with approximately $49 million in cash. Looking ahead to 2024, Benson Hill aims to transition to an asset-light business model, focusing on strategic partnerships and licensing deals. While revenues are expected to decline due to recent asset divestitures, the company anticipates enhancing earnings quality and reducing cash burn. Key performance areas for 2024 include transitioning from the legacy business model, improving operating margins, securing partnerships, optimizing capital structure, and expanding its intellectual property and technology pipeline.

Benson Hill Technical Analysis

Technical Analysis SentimentNegative
Last Price0.01

Price Trends

50DMA0.01Negative

Market Momentum

MACD-0.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BHILQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BHILQ.

Benson Hill Risk Analysis

Benson Hill disclosed 59 risk factors in its most recent earnings report. Benson Hill reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks
1.Our execution of a non-exclusive, non-binding letter of intent may or may not result in a completed transaction. The uncertainty surrounding the outcome of such transaction process could materially and adversely impact our business operations, interfere with our ability to attract and retain personnel, result in the incurrence of significant expenses and cause our stock price to be subject to significant fluctuation or otherwise be adversely impacted.Q3, 2024
2.We estimate that our existing cash and marketable securities of $14.4 million as of September 30, 2024 will last through the fourth quarter of 2024. We will require substantial additional financing, including to continue our operations, conduct necessary research and development activities and maintain covenant compliance, and, if additional financing is not available, we may need to significantly scale back operations, seek protection under the U.S. bankruptcy laws, or cease our business.Q3, 2024

Benson Hill Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

BHILQ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SEEDSEED47Neutral$10.95M-0.8388.44%―-25.50%-905.27%
AVDAVD44Neutral$32.45M-0.58-27.83%―-3.54%56.67%
RKDARKDA39Underperform$380.41K-0.02-339.85%―-12.24%17.56%
BHILQBHILQ39Underperform$60.00-82.38%―――
BIOXBIOX34Underperform$13.15M-0.06-216.09%―-26.10%14.85%

* Basic Materials Sector Average

Performance Comparison

-75%-50%-25%0%BHILQAVDSEEDRKDABIOXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
BHILQ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
BHILQBenson Hill, Inc.0.01-0.05-82.14%
AVDAmerican Vanguard Corporation1.10-3.57-76.45%
SEEDOrigin Agritech0.77-0.88-53.09%
RKDAArcadia Biosciences Inc.0.16-3.45-95.65%
BIOXBioceres Crop Solutions0.21-1.65-88.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Feb 01, 2025